Inspire Medical Systems CFO to Step Down, Initiates Search for New CFO

Inspire Medical Systems' CFO, Richard J. Buchholz, will step down by December 31, 2025, to pursue other opportunities. He will remain in an advisory role until February 28, 2026. The company reaffirms its 2025 guidance of $900-910 million in revenue. Buchholz contributed to the company's growth from $4 million to over $800 million in 2024 and guided it through its IPO and COVID-19 pandemic challenges.

Inspire Medical Systems (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea, has announced the departure of its Chief Financial Officer (CFO), Richard J. Buchholz. Buchholz will step down from his position effective December 31, 2025, to pursue other professional opportunities. He will continue to serve the company in an advisory role until February 28, 2026, to ensure a smooth transition [1].

Buchholz has been with the company since 2014 and has played a pivotal role in its growth. Under his leadership, Inspire Medical Systems achieved significant milestones, including revenue growth from $4 million to over $800 million in 2024, successful completion of its initial public offering (IPO), and reaching profitability. The company has reaffirmed its 2025 financial guidance, projecting revenue of $900-910 million, a gross margin of 84-86%, and diluted earnings per share (EPS) of $0.40-$0.50 [1].

The departure of Buchholz comes amidst a positive financial outlook for the company. Inspire Medical Systems reported a notable revenue growth rate of 10.82% as of June 30, 2025, and achieved a high gross margin of 84.03%. However, the company's EPS was -0.12, indicating potential challenges in profitability [2].

The company is actively searching for a new CFO to lead the financial division. Investors are encouraged to monitor the search process and the company's ongoing financial performance. Inspire Medical Systems' stock has shown resilience, trading at $91.62 as of the latest update, despite Buchholz's stock option exercise valued at $722,202 [2].

References:

[1] https://www.stocktitan.net/news/INSP/inspire-medical-systems-inc-announces-departure-of-chief-financial-4d0tv9i76al8.html
[2] https://www.benzinga.com/insights/news/25/08/47284708/major-exercise-alert-richard-buchholz-exercises-options-worth-722k-at-inspire-medical-systems